Glucomannan interactions on FDA labels
Interaction notes for this supplement, quoted from FDA-approved labeling.
What the FDA label says
Nateglinide section 7 (Table 2) lists glucomannan among drugs that may increase its blood-glucose-lowering effect. No CYP grade.
Cited, not graded. No interaction grade is stored for this supplement.
Educational reference only. Not FDA-cleared. The Prescribing Information governs.
Drug and product names are trademarks of their owners and are used only to identify the products.